spacer
home > pmps > autumn 2019 > lost in translation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lost in Translation




From a regulatory perspective, working primarily with chemical industrial and retail products, there are several translation challenges businesses face when looking to market their products. During the process of creating a product label, questions concerning label translations will arise: what language is required? Are there exemptions for this product? Will the necessary information fit on the label? How can the quality of the translation be ensured?

The answers to these questions depend on the country-specific regulations, the required label content, and the methods of obtaining a translation. It is important to remember that there are many entities that rely on the content of a product label. These include regulatory enforcement agencies (customs), international shipping companies, manufacturers, suppliers, distributors, and the end user (retail or workplace). Each organisation has different responsibilities regarding the product labelling. Manufacturers, suppliers, and distributors are typically responsible for the generation of compliant labels. The Globally Harmonized System (GHS) of Classification and Labelling of Chemicals can apply to retail and the workplace, which could also include pharmaceutical inputs, i.e., excipients.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Alison Senyi is a Regulatory Consultant at Nexreg Compliance, assisting with various SDS, labelling, and consulting projects. Alison finds the challenges of her regulatory role rewarding and enjoys taking an active role in bringing on new services to meet the everchanging compliance needs of the industry. Prior to joining Nexreg in 2016, she completed a Bachelorís degree at the University of Ottawa, Canada, and a Certificate of Occupational Safety and Health from Algonquin College, Canada. Alisonís background in health and safety has given her a greater understanding of the hazards of chemical products, which motivates her to promote awareness about chemical safety and compliance.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >>

White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from Indiaís pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement